132 related articles for article (PubMed ID: 33990425)
1. Twenty plus Years of Data Demonstrating Virus Filtration as an Effective and Robust Step for Large Virus Removal.
Stanley B; Holmes V; Manzari R; Romanowski C; Tessarz A; Ruppach H; Schreffler J
PDA J Pharm Sci Technol; 2022; 76(1):1-8. PubMed ID: 33990425
[TBL] [Abstract][Full Text] [Related]
2. The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim.
Banton D; Vacante D; Bulthuis B; Goldstein J; Wineburg M; Schreffler J
PDA J Pharm Sci Technol; 2019; 73(6):552-561. PubMed ID: 31101710
[TBL] [Abstract][Full Text] [Related]
3. Meeting report--workshop on virus removal by filtration: trends and new developments.
Willkommen H; Blümel J; Brorson K; Chen D; Chen Q; Gröner A; Kreil TR; Robertson JS; Ruffing M; Ruiz S
PDA J Pharm Sci Technol; 2013; 67(2):98-104. PubMed ID: 23569071
[TBL] [Abstract][Full Text] [Related]
4. Integration of Planova filters in manufacturing processes of biologicals improve the virus safety effectively: A review of publicly available data.
Gröner A
Biotechnol Prog; 2024; 40(1):e3398. PubMed ID: 37985214
[TBL] [Abstract][Full Text] [Related]
5. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
[TBL] [Abstract][Full Text] [Related]
6. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Evaluation of Cycled Resin in Viral Clearance Studies-A Multiple Company Collaboration.
Mattila J; Curtis S; Webb-Vargas Y; Wilson E; Galperina O; Roush D; Tobler S; Stanley B; Clark M; Weaver J; Pike J; Yu D; Li X; Flicker A; Kindermann J; Schuelke N; Whitcombe R; Bennett L
PDA J Pharm Sci Technol; 2019; 73(5):470-486. PubMed ID: 31101706
[TBL] [Abstract][Full Text] [Related]
8. Virus filter scalability: Demonstration of consistent viral clearance across laboratory and manufacturing scales.
Buesing B; Schwartz A; Shah A; Sohka T; Hirotomi N; Strauss D
Biologicals; 2021 Jul; 72():27-32. PubMed ID: 34226123
[TBL] [Abstract][Full Text] [Related]
9. Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.
Gefroh E; Dehghani H; McClure M; Connell-Crowley L; Vedantham G
PDA J Pharm Sci Technol; 2014; 68(3):297-311. PubMed ID: 25188350
[TBL] [Abstract][Full Text] [Related]
10. Serial virus filtration: A case study evaluating the product-dependent impact of control strategies on process efficiency.
Kozaili J; Shah A; Robbins D; Brinkman N; Burdick M; Strauss D
Biotechnol J; 2023 Sep; 18(9):e2200599. PubMed ID: 37218550
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to achieving modular retrovirus clearance for a parvovirus filter.
Stuckey J; Strauss D; Venkiteshwaran A; Gao J; Luo W; Quertinmont M; O'Donnell S; Chen D
Biotechnol Prog; 2014; 30(1):79-85. PubMed ID: 24123923
[TBL] [Abstract][Full Text] [Related]
12. Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations-Virus Filtration/Inactivation.
Kreil TR; Roush D
PDA J Pharm Sci Technol; 2018; 72(5):470-478. PubMed ID: 30030356
[TBL] [Abstract][Full Text] [Related]
13. Proceedings of the 2019 Viral Clearance Symposium, Session 6: Virus-Retentive Filtration.
O'Donnell S; Bolton G
PDA J Pharm Sci Technol; 2022; 76(4):349-357. PubMed ID: 34911825
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the impact of pressure on virus filtration processes and establishing design spaces to ensure effective parvovirus removal.
Strauss D; Goldstein J; Hongo-Hirasaki T; Yokoyama Y; Hirotomi N; Miyabayashi T; Vacante D
Biotechnol Prog; 2017 Sep; 33(5):1294-1302. PubMed ID: 28556575
[TBL] [Abstract][Full Text] [Related]
15. Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles.
Adan-Kubo J; Tsujikawa M; Takahashi K; Hongo-Hirasaki T; Sakai K
Biotechnol Prog; 2019 Nov; 35(6):e2875. PubMed ID: 31228338
[TBL] [Abstract][Full Text] [Related]
16. Adapting virus filtration to enable intensified and continuous monoclonal antibody processing.
Bohonak DM; Mehta U; Weiss ER; Voyta G
Biotechnol Prog; 2021 Mar; 37(2):e3088. PubMed ID: 33016523
[TBL] [Abstract][Full Text] [Related]
17. Development of a transient inline spiking system for evaluating virus clearance in continuous bioprocessing-Proof of concept for virus filtration.
Malakian A; Jung SY; Afzal MA; Carbrello C; Giglia S; Johnson M; Miller C; Rayfield W; Boenitz D; Cetlin D; Zydney AL
Biotechnol Bioeng; 2022 Aug; 119(8):2134-2141. PubMed ID: 35470427
[TBL] [Abstract][Full Text] [Related]
18. Cellulose-based virus-retentive filters: a review.
Junter GA; Lebrun L
Rev Environ Sci Biotechnol; 2017; 16(3):455-489. PubMed ID: 32214924
[TBL] [Abstract][Full Text] [Related]
19. The evolution of down-scale virus filtration equipment for virus clearance studies.
Wieser A; Berting A; Medek C; Poelsler G; Kreil TR
Biotechnol Bioeng; 2015 Mar; 112(3):633-7. PubMed ID: 25220795
[TBL] [Abstract][Full Text] [Related]
20. Virus clearance by activated carbon for therapeutic monoclonal antibody purification.
Kikuchi S; Ishihara T; Yamamoto K; Hosono M
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1195():123163. PubMed ID: 35240387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
